SYNCOM

Syncom Healthcare Limited has informed the Exchange that the Company is pleased to provide members facility to exercise their right to vote at AGM by electronic means and the business may be transacted through e-voting services provided by CDSL at the link www.evotingindia.com. The e-voting period shall commence on September 23, 2014 and ends on September 24, 201. During this period shareholder of the Company, holding shares either in physical form or in dematerialized form, as on the cut-off date of August 22, 2014, may cast their vote electronically.

Syncom Healthcare Limited has informed the Exchange that : "We wish to inform you that the Local Administration has visited our office on 6th September 2014 for an inquiry based on a complaint. They issued us a Show cause Notice that was replied in detailed on MOnday, 8th September 2014 along with all the relevant documents, papers, certificates, etc. It was alleged that the company has collected money from the various persons without obtaining the registration from the Reserve Bank of India. In the reply it is submitted that the Company has not taken from any one any money as deposit/ investm

Syncom Healthcare Limited has informed the Exchange that the Company has appointed Mr. J.C. Paliwal, a qualified Company Secretary as the Company Secretary & Compliance Officer of the Company with effect from August 30, 2014.

Syncom Healthcare Limited has informed the Exchange that the Meeting of the Board of Directors of the Company held on August 14, 2014, has transacted the following business: 1. The Board has approved appointment of Mr. Manish Maheshwari, Practicing Company Secretary as a Scrutinizer for e-voting. 2. The Board has approved appointment of M/s. M Maheshwari & Associates, Practicing Company Secretary for Secretarial Audit for the financial year 2014-15.

Syncom Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from September 23, 2014 to September 30, 2014 (both day inlcusive) for the purpose of Annual General Meeting of the Company schedule to be held on September 30, 2014.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2014.

Syncom Healthcare Limited has informed the Exchange that as per the Company's Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India ( Prohibition of Insider Trading ) Regulation, 1992, the Trading Window for dealing in Equity Shares of the Company shall remain closed from August 5,2014 to August 16,2014 ( both days inclusive ) for the purpose of Un-audited financial Result of the Company for the Quarter ended June 30,2014 for all Directors/Officers/Designated employees of the Company.

Syncom Healthcare Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-mar-2014.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results for the period ended 31-dec-2013.

Syncom Healthcare Limited has informed the Exchange that as per the Company s Code of Conduct for Prevention of Insider Trading read with Securities and Exchange Board of India (Prohibition of Insider Trading Regulation) 1992, the Trading Window for dealing in Securities of the Company will remain closed for the purpose of declaration of Unaudited Financial Results of the Company for the 3rd Quarter and Nine Months ended on December 31, 2013 for all Directors/Officers/Designated employees of the Company from February 04, 2014 to February 15, 2014.

Syncom Healthcare Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.

Syncom Healthcare Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 30, 2013.

Syncom Healthcare Limited has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 30, 2013. The Register of Members and the Share Transfer Books of the Company will remain closed from September 27, 2013 to September 30, 2013 (both days inclusive) for the purpose of the Annual General Meeting of the Company.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.

Syncom Healthcare Limited has informed the Exchange that Mr. Pratik Bankda has been appointed as an Additional Director of the Company w.e.f. June 11, 2013 for further strengthening the Board of the Company.

Syncom Healthcare Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.

Jyoti Bankda has submitted to the Exchange vide letter dated April 25, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Jyoti Bankda has submitted to the Exchange, vide letter dated April 22, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ajay S. Bankda has submitted to the Exchange vide letter dated April 22, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ajay S. Bankda has submitted to the Exchange vide letter dated March 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has informed the Exchange that the Company have designated Mr. Subhash Chandra Gupta as 'Vice-President - Finance & Accounts' of the Company with effect from March 22, 2013, in place of Mr. Naveen Sood, erstwhile Chief Financial Officer of the Company. Further, the Company has informed the Exchange that Mr. Subhash Chandra Gupta will also act as Compliance Officer for the purposes of Clause 47(a) and other applicable clauses of Listing Agreement in place of Mr. Naveen Sood effective March 22, 2013.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended December 31,2012.

Jyoti Bankda has submitted to the Exchange vide letter dated January 31, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has informed the Exchange vide letter dated January 16, 2013, titled "Syncom Healthcare Ltd signs Supply Agreement with Whyte International Ltd UK".

Ajay S Bankda has submitted to the Exchange vide its letter dated December 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.

Jyoti Bankda has submitted to the Exchange vide its letter dated November 02, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ajay S. Bankda has submitted to the Exchange vide letter dated October 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has informed the Exchange regarding the Proceedings of the Annual General Meeting of the Company held on September 29, 2012.

Syncom Healthcare Limited has informed the Exchange that the Company have designated Mr. Naveen Sood 'Chief Financial Officer' of the Company with effect from September 01, 2012. Further, Mr. Sood will act as Compliance Officer in place of Mr. Atul Thapliyal effective September 01, 2012.

Syncom Healthcare Limited has informed the Exchange that the Annual General Meeting of the Company will be held on September 29, 2012. The Register of Members and the Share Transfer Books of the Company shall remain closed from September 26, 2012 to September 29, 2012 (both days inclusive) for the purpose of the Annual General Meeting of the Company.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012 along with Limited Review Report for the period ended June 30,2012.

Jyoti Bankda has submitted to the Exchange vide its letter dated August 07, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ajay Bankda has submitted to the Exchange vide letter dated August 08, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Jyoti Bankda has submitted to the Exchange vide letter dated August 06, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Syncom Healthcare Limited has informed the Exchange that Mr. Atul Thapliyal have been appointed as Compliance Officer of the Company w.e.f. July 12, 2012.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2012.

Syncom Healthcare Limited has informed the Exchange that Mr. J. C. Paliwal, Company Secretary of the Company has tendered his resignation from the post of Company Secretary to be effective from May 24, 2012 at the close of the working hours.

Syncom Healthcare Limited has informed the Exchange vide its letter dated February 29, 2012 regarding the Results of Postal Ballot.

Syncom Healthcare Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31, 2011 (taken on record by the Board of Directors of the Company at its meeting held on February 14, 2012) regarding the Utilisation of funds.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended December 31,2011.

Syncom Healthcare Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2011 (taken on record by the Board of Directors of the Company at its meeting held on November 14, 2011) regarding the Utilisation of funds.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

Syncom Healthcare Limited has informed the Exchange that the Annual General Meeting of the Company will be held on September 30, 2011. The Register of Members and the Share Transfer Books of the Company shall remain closed from September 27, 2011 to September 30, 2011 (both days inclusive) for the purpose of the Annual General Meeting of the Company.

Syncom Healthcare Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2011 (taken on record by the Board of Directors of the Company at its meeting held on August 12, 2011) regarding the Utilisation of funds.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Syncom Healthcare Limited has informed the Exchange vide notes to Accounts in the Unaudited financial results for the quarter ended December 31, 2010 (taken on record by the Board of Directors of the Company at its meeting held on February 15, 2011) regarding details of utilization of funds received from Initial Public Offer of equity shares up to December 31, 2010.

Syncom Healthcare Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

Syncom Healthcare Limited has informed the Exchange that the Company is proposing to set up a subsidiary unit in RAK Free Trade Zone, Dubai as a free zone establishment for the purpose of trading of the pharmaceutical products and other commodities. For this, the Company is proposing to have a flexi office for the time being and then to move for a standard office with the increase in the trading activities.